Article Text

Download PDFPDF
Treatment for late-onset Pompe's disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Pompe's disease has a birth prevalence of about 1 in 40 000 in the USA and some 5000–10 000 people are thought to be affected worldwide. The main difference between the infantile and the late-onset forms is the presence of cardiomyopathy in the infantile form. The cause is a mutation (>200 have been described) in the autosomal recessive acid α-glucosidase …

View Full Text


  • Provenance and peer review Commissioned; internally peer reviewed.